Rigel Pharmaceuticals, Inc.
NASDAQ:RIGLBiotechnology
Healthcare
$42.53 -1.86%
-$0.62 today
- Market cap
- $800.84M
- Beta
- 1.18
- P/E (TTM)
- 1.7
- EPS (TTM)
- $19.78
52W Low $18.14High $52.24
Volume 0.24M
Average 0.36M
Balance Sheet
Inspect the capital base behind the business.
Assets
$513.59M
FY 2025 · Annual
+213.2% YoYLiabilities
$122.11M
FY 2025 · Annual
-24.0% YoYEquity
$391.48M
FY 2025 · Annual
+11806.3% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 18.89M | 24.46M | 32.79M | 56.75M | 40.58M |
| Short-term Investments | 106.08M | 33.75M | 24.15M | 20.58M | 114.38M |
| Net Receivables | 15.47M | 40.32M | 30.55M | 41.62M | 51.76M |
| Inventory | 6.62M | 9.12M | 5.52M | 6M | 11.51M |
| Other Current Assets | 0 | 8.26M | 6.26M | 10.17M | 21.94M |
| Total Current Assets | 154.47M | 115.9M | 99.27M | 135.1M | 240.17M |
| Property, Plant & Equipment (Net) | 11.89M | 2.79M | 1.03M | 338K | 920K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 14.95M | 13.88M | 27.1M | 24.75M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 245.85M |
| Other Non-current Assets | 974K | 640K | 3.06M | 1.44M | 1.91M |
| Total Non-current Assets | 12.86M | 18.38M | 17.96M | 28.87M | 273.43M |
| Total Assets | 167.33M | 134.28M | 117.23M | 163.98M | 513.59M |
| Account Payables | 3.8M | 22.51M | 7.14M | 3.34M | 7.19M |
| Short-term Debt | 0 | 0 | 7.23M | 7.27M | 30.43M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 10.51M | 13.51M | 17.04M | 27.8M | 1.36M |
| Other Current Liabilities | 24.2M | 13.86M | 12.32M | 10.14M | 48.35M |
| Total Current Liabilities | 63.55M | 65.21M | 53.27M | 63.3M | 99.24M |
| Long-term Debt | 19.91M | 39.45M | 52.37M | 52.41M | 22.88M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 52.73M | 42.26M | 39.94M | 44.98M | 0 |
| Total Non-current Liabilities | 73.4M | 82.68M | 92.6M | 97.39M | 22.88M |
| Total Liabilities | 136.95M | 147.9M | 145.87M | 160.69M | 122.11M |
| Common Stock | 172K | 174K | 17K | 18K | 18K |
| Retained Earnings | (1.32B) | (1.38B) | (1.41B) | (1.39B) | (1.02B) |
| Accumulated OCI | (102K) | (153K) | 8K | 10K | 181K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 30.37M | (13.62M) | (28.64M) | 3.29M | 391.48M |
| Total Debt | 30.57M | 41.55M | 60.58M | 59.97M | 53.3M |
| Net Debt | 11.68M | 17.09M | 27.79M | 3.22M | 12.72M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $24.4M |
| Short-term Investments | $122.3M |
| Receivables | $49.9M |
| Inventory | $11.7M |
| Other Current | $25.7M |
| Total Current Assets | $234.0M |
| PP&E (Net) | $785.0K |
| Intangible Assets | $24.2M |
| Tax Assets | $243.3M |
| Other Non-current | $2.4M |
| Total Non-current Assets | $270.6M |
| Total Assets | $504.6M |
Analysis
Selected assets total $504.6M for Latest. The largest visible component is Tax Assets at $243.3M, about 48.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Nov 10, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 3, 2026 |
How much cash does RIGL have?
Rigel Pharmaceuticals, Inc. (RIGL) reported $40.58M in cash and equivalents in fiscal 2025.
How much debt does RIGL carry?
Rigel Pharmaceuticals, Inc. (RIGL) reported $53.30M of total debt, with net debt of $12.72M.
Continue the stock analysis
Jump to another research area for this company.